期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 13, 期 6, 页码 661-668出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERA.13.58
关键词
bladder cancer; chemotherapy; comparative effectiveness research; quality of care; quality of life; radical cystectomy
类别
资金
- National Cancer Institute
- Florida Bankhead Coley Cancer Research Program
- Florida Department of Health
Bladder cancer is the most expensive cancer per capita to treat in the US healthcare system. Substantial costs associated with the diagnosis, management and surveillance of bladder cancer account for the bulk of the expense; yet, for that cost, patients may not receive high-quality care. Herein the authors review the sources of expenditure associated with bladder cancer care, review population-level analyses of the quality of bladder cancer care in the USA, and discuss opportunities for quality improvement that may yield greater value for men and women newly diagnosed with bladder cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据